PATENT CLAIM ANALYSIS

Application Number: 15879806
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "465000"]

Abstract:
Disclosed herein are pharmaceutically acceptable rapid dissolve vaginal tablet compositions comprising one or more active pharmaceutical ingredients suitable for therapy via topical action or systemic absorption, and methods of making and using such compositions.

Claim (Index 23):
The method of  claim 22 , further comprising administering a pharmaceutical composition of claim  1 ,  11 ,  15 ,  16  or  17  containing therapeutically effective amounts of tenofovir and emtricitabine into the vagina of a patient or subject for the treatment of HIV infection.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 86.0
- Lexical Diversity: 1.09091
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14917125', '15387317', '14743026', '13974725', '10827106']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6895409688477581
- 35 USC 102 Novelty (BERT): 0.528098165256819
- Combined Prediction Score: 0.6733966884886642
- Mean Citation Score: 252.85325200000003
- Max Citation Score: 272.79074
- Similarity Product: 139.31458519506694

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test